Vetinnova
PORTAL DE REFERENCIA SOBRE I+D+i
EN SANIDAD ANIMAL
 

Área Personal

Acceso al área privada de la web
Búsqueda de texto en la web

fbus

CREA TU PERFIL Grupo de Investigación
Grupo de Investigación
CREA TU PERFIL Empresa
Empresa

 Biogelator

Material based on short, tunable amphipathic hexapeptide sequences that form hydrogels upon addition of aqueous media The technology can be used as a generic controlled drug delivery formulation for the treatment of various chronic diseases, suited for the extended release of small molecule drugs and biologicals of medium- to high molecular weight drugs. Additionally, it can be used in other areas like tissue engineering, where soft matters are highly valuable. Proof of concept The BioGelator technology was first developed for pain therapy, and other biomedical and therapeutic applications are currently under investigation. The in vivo efficacy of BioGelator formulations was demonstrated via monitoring of opioid-induced antinociceptive effects in mice using the tail-flick test.
Peptide-based hydrogels for controlled drug-delivery
· Nombre de contacto Sven Arnouts
· Correo electrónico sven.arnouts@ugent.be
· Teléfono +32 495 707 334
· Socio buscado We are seeking partners/collaborators that are interested to further develop our technology in the current application towards clinical trials. We are also interested in partnerships willing to investigate the potential of the BioGelator
Una iniciativa de

Vet + i
Vetdivulga
Ayuda PTR2022-001249 financiada por:

UNION EUROPEA - FONDO EUROPEO DE DESARROLLO REGIONAL